More than one year after its inception, the coronavirus disease 2019 (COVID-19) pandemic
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) remains difficult …

Omicron Neutralization after the Third Vaccine Dose Neutralization assays of SARS-CoV-2
pseudoviruses expressing wild-type, omicron, or a synthetic resistant spike protein in plasma …

Global population immunity to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
is accumulating through heterogeneous combinations of infection and vaccination. …

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection produces B cell
responses that continue to evolve for at least a year. During that time, memory B cells express …

The Omicron variant of SARS-CoV-2 infected many vaccinated and convalescent individuals
1 , 2 – 3 . Despite the reduced protection from infection, individuals who received three …

The number and variability of the neutralizing epitopes targeted by polyclonal antibodies in
individuals who are SARS-CoV-2 convalescent and vaccinated are key determinants of …

The emergence of SARS-CoV-2 and the ensuing explosive epidemic of COVID-19 disease
has generated a need for assays to rapidly and conveniently measure the antiviral activity of …

Individuals who receive a third mRNA vaccine dose show enhanced protection against
severe COVID-19, but little is known about the impact of breakthrough infections on memory …

The omicron variant of SARS-CoV-2 infected very large numbers of SARS-CoV-2
vaccinated and convalescent individuals 1 – 3 . The penetrance of this variant in the antigen …

The SARS-CoV-2 pandemic prompted a global vaccination effort and the development of
numerous COVID-19 vaccines at an unprecedented scale and pace. As a result, current COVID…